Polyneuritis Interstitial Hypertrophic Progressive

Topic: Polyneuritis Interstitial Hypertrophic Progressive

Interstitial hypertrophic progressive polyneuritis (PIP) is a disease of the nervous system that can lead to serious health consequences, including sensory impairment and paralysis. This disease manifests itself as inflammation

Polyneuritis (PNS) Interstitial Hypertrophic Progressive (IPHP, Interstitial Hypertrophic Progressive Neuropathy) is a rare and not very well studied disease of the nervous system, in which the functioning of the peripheral nerves of the extremities is gradually impaired. The cause of the disease still remains unknown, although scientists have put forward various theories. With this type of PNHP, more than 70% of peripheral nerve fibers are affected, usually in combination with demyelination of their sheath. In cases of severe clinical manifestations, patients complain of numbness, tingling, weakness and pain in the extremities.

Unfortunately, other than general symptoms, it is very difficult to accurately determine the extent of nerve damage, and a more accurate determination of the severity of the disease is only possible through laboratory testing. If the diagnosis is accurate enough, healthcare providers can choose the right course of treatment to help the patient improve their quality of life. For example, patients with this type of PNHP may be given corticosteroid injections into the bursa, and physical therapy may be prescribed to relieve tension and speed up the healing process. In addition, patients are advised to take care of their limbs, avoiding excessive physical exertion, hypothermia and pressure on the affected areas. Treatment of this rare disease requires a lot of time and patience, but